Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance. [electronic resource]
Producer: 20111017Description: 4155-66 p. digitalISSN:- 1557-3265
- Adenocarcinoma -- diagnosis
- Antineoplastic Agents -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Down-Regulation
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic
- Gene Silencing
- Humans
- Inhibitor of Differentiation Protein 1 -- genetics
- Neoplasm Staging
- Prognosis
- RNA, Messenger -- genetics
- RNA, Small Interfering -- genetics
- Radiation Tolerance -- genetics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.